CIB 1st Quarter Separate Financial Results

RNS Number : 5016Z
Commercial Intnl Bank (Egypt) SAE
24 May 2021
 

 

 

Commercial International Bank (Egypt) S.A.E.

Separate Financial Statements

March 31, 2021

Click on, or paste the following link into your web browser, to view the associated PDF document.

http://www.rns-pdf.londonstockexchange.com/rns/5016Z_1-2021-5-21.pdf

 

 

Condensed Separate Interim Balance Sheet as at March 31,2021

 

 

Notes

Mar. 31, 2021

 

Dec. 31, 2020

 

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

 

 

Assets

 

 

 

 

 

Cash and balances at the central bank

7

21,580,813

 

33,572,597

 

Due from  banks

8

97,069,002

 

86,997,034

 

Loans and advances to banks, net

10

781,084

 

776,980

 

Loans and advances to customers, net

11

120,303,607

 

118,854,880

 

Derivative financial instruments

 

290,438

 

248,759

 

Investments

 

 

 

 

 

- Financial Assets at Fair Value through P&L

12

341,120

 

359,959

 

- Financial Assets at Fair Value through OCI

12

167,580,005

 

147,646,432

 

- Amortized cost

12

24,677,774

 

25,020,917

 

- Investments in associates and subsidiaries

13

1,032,708

 

874,348

 

Other assets

 

9,424,894

 

9,095,212

 

Deferred tax assets (Liabilities)

 

431,534

 

437,772

 

Property and equipment

14

2,466,612

 

2,259,940

 

Total assets

 

445,979,591

 

426,144,830

 

Liabilities and equity

 

 

 

 

 

Liabilities

 

 

 

 

 

Due to banks

15

2,511,475

 

8,815,561

 

Due to customers

16

365,162,571

 

340,086,524

 

Derivative financial instruments

 

306,569

 

331,073

 

Current tax liabilities

 

830,536

 

859,582

 

Other liabilities

 

6,763,064

 

5,679,266

 

Other loans

 

7,732,536

 

7,746,946

 

Provisions

17

3,270,735

 

3,221,252

 

Total liabilities

 

386,577,486

 

366,740,204

 

Equity

 

 

 

 

 

Issued and paid up capital

 

14,776,813

 

14,776,813

 

Reserves

 

40,231,425

 

33,085,554

 

Reserve for employee stock ownership plan (ESOP)

 

1,227,099

 

1,064,648

 

Retained earnings *

 

3,166,768

 

10,477,611

 

Total equity and net profit for the period / year

 

59,402,105

 

59,404,626

 

Total liabilities and equity

 

445,979,591

 

426,144,830

 

 

 

 

 

 

 

 

 

 

 

 

 

The accompanying notes are an integral part of these financial statements.

 

 

 

 

 

(Review report attached)

 

 

 

 

*

Including net profit for the current period

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hussein Abaza

Sherif Samy

 

CEO & Board member

Chairman

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Separate Interim Income Statement for the period ended March 31, 2021

 

 

 

 

 

 

 

 

 

 

 

 

 

Notes

 

Mar. 31, 2021

Mar. 31, 2020

 

 

 

 

 

 

 

 

EGP Thousands

EGP Thousands

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest and similar income

 

 

10,120,581

10,687,101

 

 

 

 

 

Interest and similar expense

 

 

(4,444,196)

(4,491,834)

 

 

 

 

 

Net interest income

 

 

5,676,385

6,195,267

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fee and commission income

 

 

844,128

805,413

 

 

 

 

 

Fee and commission expense

 

 

(333,561)

(305,561)

 

 

 

 

 

Net fee and commission income

 

 

510,567

499,852

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dividend income

 

 

91

-

 

 

 

 

 

Net trading income

5

 

112,718

(5,425)

 

 

 

 

 

Profits (Losses) on financial investments 

12

 

493,655

470,150

 

 

 

 

 

Administrative expenses

 

 

(1,472,944)

(1,523,538)

 

 

 

 

 

Other operating (expenses) income

 

 

(526,604)

(747,740)

 

 

 

 

 

Impairment release (charges) for credit losses

 

 

(702,082)

(1,240,110)

 

 

 

 

 

Profit before income tax

 

 

4,091,786

3,648,456

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income tax expense

 

 

(1,209,247)

(1,332,487)

 

 

 

 

 

Deferred tax assets (Liabilities)

 

 

(6,239)

75,241

 

 

 

 

 

Net profit for the period

 

 

2,876,300

2,391,210

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earning per share

6

 

 

 

 

 

 

 

 

Basic

 

 

1.72

1.43

 

 

 

 

 

Diluted

 

 

1.71

1.42

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hussein Abaza

 

Sherif Samy

 

 

 

 

 

 

CEO & Board member

 

Chairman

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Separate Interim statement of Comprehensive Income for the period ended March 31, 2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Mar. 31, 2021

 

Mar. 31, 2020

 

 

 

 

 

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

 

 

 

 

 

 

Net profit for the period

 

 

 

2,876,300

 

2,391,210

 

 

 

 

 

 

 

 

 

 

 

Change in fair value of debt instruments measured at fair value through other comprehensive income

Transferred from reserve on disposal of financial assets at fair value through OCI

Effect of ECL in fair value of debt instruments measured at fair value through OCI

Total comprehensive income for the period

 

 

 

 

(1,674,309)

(104,406)

(14,644)

1,082,941

 

 

(4,865,970)

-

(47,321)

(2,522,081)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Separate Interim Cash flows for the period ended March 31, 2021

 

 

Notes

Mar. 31, 2021

 

Mar. 31, 2020

 

 

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

 

 

Cash flow from operating activities

 

 

 

 

 

Profit before income tax

 

4,091,786

 

3,648,456

 

Adjustments to reconcile net profit to net cash provided by operating  activities

 

 

 

 

 

Fixed assets depreciation

14

194,609

 

160,538

 

Impairment charge for credit losses (Loans and advances to customers and banks)

 

720,756

 

1,272,649

 

Other provisions charges

17

114,144

 

439,410

 

Impairment charge for credit losses (due from banks)

 

(4,030)

 

14,782

 

Impairment charge for credit losses (financial investments)

 

(14,644)

 

(47,321)

 

Impairment charge for other assets

 

12,676

 

13,707

 

Exchange revaluation differences for financial assets at fair value through OCI

 

23,042

 

287,889

 

Impairment charge financial assets at fair value through OCI

 

(72,957)

 

69,863

 

Exchange differences in financial investments in subsidiary

 

-

 

719

 

Utilization of other provisions

17

(43,518)

 

(726)

 

Other provisions no longer used

17

(5,872)

 

(38,630)

 

Exchange differences of  other provisions

17

(15,271)

 

(22,219)

 

(Profits) losses from selling property, plant and equipment

 

(1,250)

 

(94)

 

(Profits) losses from selling financial investments

12

(420,698)

 

(554,113)

 

Shares based payments

 

162,451

 

145,069

 

Released (Impairment) charges of investments in associates and subsidiaries

 

-

 

14,100

 

Operating profits before changes in operating assets and liabilities

 

4,741,224

 

5,404,079

 

 

 

 

 

 

 

Net decrease (increase) in assets and  liabilities

 

 

 

 

 

Due from banks

 

(12,278,859)

 

211,025

 

Financial assets at fair value through P&L

12

18,839

 

104,116

 

Derivative financial instruments

 

(66,183)

 

35,892

 

Loans and advances to banks and customers

10 - 11

(2,173,587)

 

2,428,551

 

Other assets

 

(284,984)

 

857,769

 

Due to banks

15

(6,304,086)

 

(1,372,684)

 

Due to customers

16

25,076,047

 

5,513,465

 

Income tax obligations paid

 

(29,046)

 

(4,639,364)

 

Other liabilities

 

(236,449)

 

(722,423)

 

Net cash used in (generated from) operating activities

 

8,462,916

 

7,820,426

 

 

 

 

 

 

 

Cash flow from investing activities

 

 

 

 

 

 

 

 

 

 

 

Proceeds (payments) for investment in associates.

 

(158,360)

 

-

 

Payment for purchases of property, plant, equipment and branches
 constructions

 

(347,656)

 

(319,089)

 

Proceeds from selling property, plant and equipment

 

1,250

 

94

 

Proceeds from redemption of financial assets at amortized cost

 

346,898

 

45,639,889

 

Payment for purchases of financial assets at amortized cost

 

(3,844)

 

(44,945,839)

 

Payment for purchases of financial assets at fair value through OCI

 

(55,216,492)

 

(62,050,349)

 

Proceeds from selling financial assets at fair value through OCI

 

34,497,956

 

54,866,521

 

Net cash generated from (used in) investing activities

 

(20,880,248)

 

(6,808,773)

 

 

Condensed Separate Interim Cash flows for the period ended March 31, 2021 (Cont.)

 

 

 

 

 

 

 

 

 

 

Mar. 31, 2021

 

Mar. 31, 2020

 

 

 

EGP Thousands

 

EGP Thousands

 

 

 

 

 

 

 

Cash flow from financing activities

 

 

 

 

 

Received (Repaid) in long term loans

 

(14,410)

 

(91,576)

 

Dividend paid

 

(1,360,652)

 

(3,370,464)

 

Net cash generated from (used in) financing activities

 

(1,375,062)

 

(3,462,040)

 

 

 

 

 

 

 

 

 

 

 

 

 

Net increase (decrease) in cash and cash equivalent during the period

 

(13,792,394)

 

(2,450,387)

 

Beginning balance of cash and cash equivalent

 

75,965,247

 

22,895,017

 

Cash and cash equivalent at the end of the period

 

62,172,853

 

20,444,630

 

 

 

 

 

 

 

Cash and cash equivalent comprise:

 

 

 

 

 

Cash and balances at the central bank

 

21,580,813

 

27,169,495

 

Due from banks

 

97,088,303

 

26,640,005

 

Treasury bills and other governmental  notes

 

52,339,135

 

29,091,960

 

Obligatory reserve balance with CBE

 

(15,671,568)

 

(22,186,285)

 

Due from banks with maturities more than three months

 

(40,498,431)

 

(10,415,104)

 

Treasury bills with maturity more than three months

 

(52,665,399)

 

(29,855,441)

 

Total cash and cash equivalent

 

62,172,853

 

20,444,630

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Separate Interim statement of  changes in shareholders' equity  for the period ended March 31, 2020

 

Mar. 31, 2020

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

 

 

 

 

 

 

 

 

 

 

 

EGP Thousands

 

Beginning balance

14,690,821

2,188,029

16,474,429

1,549,445

13,466

4,111,781

5,164

11,803,555

963,152

51,799,842

 

Transferred to reserves

-

590,106

7,840,286

-

1,440

-

-

(8,431,832)

-

-

 

Dividend paid

-

-

-

-

-

-

-

(3,370,464)

-

(3,370,464)

 

Net profit for the period

-

-

-

-

-

-

-

2,391,210

-

2,391,210

 

Net unrealised gain/(loss) on financial assets at fair value through OCI

-

-

-

-

-

(4,865,970)

-

-

-

(4,865,970)

 

Transferred (from) to  bank risk reserve

-

-

-

-

-

-

1,259

(1,259)

-

-

 

ECL for impairment of debt instruments investments

-

-

-

-

-

(47,321)

-

-

-

(47,321)

 

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

145,069

145,069

 

Ending balance

14,690,821

2,778,135

24,314,715

1,549,445

14,906

(801,510)

6,423

2,391,210

1,108,221

46,052,366

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Condensed Separate Interim statement of changes in shareholders' equity for the period ended March 31, 2021

 

 

 

 

 

 

 

 

 

 

 

 

 

Mar. 31, 2021

Issued and paid up capital

Legal reserve

General reserve

General risk reserve

Capital reserve

Reserve for financial assets at fair value through OCI

Banking risks reserve

Retained earnings

Reserve for employee stock ownership plan

Total

 

 

 

 

 

 

 

 

 

 

 

EGP Thousands

 

Beginning balance

14,776,813

2,778,135

24,765,658

1,549,445

14,906

3,970,987

6,423

10,477,611

1,064,648

59,404,626

 

Transferred to reserves

-

514,939

8,420,479

-

1,094

-

-

(8,936,512)

-

-

 

Dividend paid

-

-

-

-

-

-

-

(1,360,652)

-

(1,360,652)

 

Net profit for the period

-

-

-

-

-

-

-

2,876,300

-

2,876,300

 

Transferred from reserve on disposal of financial assets at fair value through OCI

-

-

-

-

-

(104,406)

-

104,406

-

-

 

 

 

 

 

 

 

 

 

 

 

 

 

Transferred from previous years' outstanding balances

-

-

-

-

-

-

-

8,333

-

8,333

 

Net unrealised gain/(loss) on financial assets at fair value through OCI

-

-

-

-

-

(1,674,309)

-

-

-

(1,674,309)

 

Transferred (from) to  banking risk reserve

-

-

-

-

-

-

2,718

(2,718)

-

-

 

Effect of ECL in fair value of debt instruments measured at fair value through OCI

-

-

-

-

-

(14,644)

-

-

-

(14,644)

 

Cost of employees stock ownership plan (ESOP)

-

-

-

-

-

-

-

-

162,451

162,451

 

 

Ending balance

14,776,813

3,293,074

33,186,137

1,549,445

16,000

2,177,628

9,141

3,166,768

1,227,099

59,402,105

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRFUAONRABUVUAR
UK 100

Latest directors dealings